ClinicalTrials.Veeva

Menu

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

C

Carol Fabian, MD

Status

Withdrawn

Conditions

Breast Cancer

Treatments

Procedure: Fine needle aspiration

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

A study to examine the potential associations between common single nucleotide polymorphisms and pre-cancerous conditions in breast tissue specimens from postmenopausal women.

Full description

A study to examine the correlation between single nucleotide polymorphisms (SNPs) affecting steroid and carcinogen metabolism and benign breast tissue cytomorphology collected via random periareolar fine needle aspiration in postmenopausal women at increased risk for breast cancer and taking hormone replacement therapy.

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • postmenopausal women on or off hormone replacement therapy
  • at high risk of developing breast cancer determined by family or personal history
  • postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration
  • willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies

Exclusion criteria

  • women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.

Trial design

0 participants in 1 patient group

1
Description:
Post-menopausal women who are at increased risk for development of breast cancer on the basis of family or personal history.
Treatment:
Procedure: Fine needle aspiration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems